| [18 F]-and [11 C]-Labeled N-benzyl-isatin sulfonamide analogues as PET tracers for Apoptosis: synthesis, radiolabeling mechanism, and in vivo imaging study of apoptosis in Fas … D Zhou, W Chu, DL Chen, Q Wang, DE Reichert, J Rothfuss, A D'Avignon, ... Organic & biomolecular chemistry 7 (7), 1337-1348, 2009 | 94 | 2009 |
| [18F] fluorodeoxyglucose positron emission tomography for lung antiinflammatory response evaluation DL Chen, TJ Bedient, J Kozlowski, DB Rosenbluth, W Isakow, TW Ferkol, ... American journal of respiratory and critical care medicine 180 (6), 533-539, 2009 | 52 | 2009 |
| [68Ga]-PSMA-11 can clarify equivocal lesions on conventional imaging and change management decisions among men with previously treated prostate cancer A Gulhane, D Lin, A Dash, W Ellis, Y Nyame, G Schade, J Wright, ... Journal of Nuclear Medicine 63 (supplement 2), 3065-3065, 2022 | 2 | 2022 |
| 1470 Combining the antigen-presenting cell activator eftilagimod alpha (soluble LAG-3) and pembrolizumab: efficacy results from the 1st line non-small cell lung cancer cohort … W Iams, E Felip, M Majem, B Doger, T Clay, E Carcereny, I Bondarenko, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 3 | 2022 |
| A hybrid CNN-Swin Transformer network as deep learning model observer to predict human observer performance in 2AFC trial M Shao, J Mitra, DW Byrd, CK Abbey, F Behnia, JH Lee, A Iravani, ... Medical Imaging 2024: Image Perception, Observer Performance, and Technology …, 2024 | | 2024 |
| A poly (adp-ribose) polymerase-1 (parp-1) inhibitor and uses therefor R Mach, W Chu, D Zhou, L MICHEL, C Delphine | | 2019 |
| Abstract CT132: iPREDICT trial: A phase IIb, open label study of 89Zr-Crefmirlimab Berdoxam PET/CT in subjects with selected advanced malignancies (melanoma … K Margolin, D Hays, DL Chen, G Ulaner, R Korn, K Young, M Ferris, W Le, ... Cancer Research 82 (12_Supplement), CT132-CT132, 2022 | 1 | 2022 |
| Abstract P2-03-17: Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2+ or HER2-metastatic breast cancer N Hunter, LM Peterson, DA Mankoff, M Muzi, D Chen, WR Gwin, ... Cancer Research 83 (5_Supplement), P2-03-17-P2-03-17, 2023 | | 2023 |
| Abstract PD6-10: 18F-fluoroestradiol (fes) and 18f-fluorodeoxyglucose (fdg) pet imaging in metastatic lobular breast cancer P Manohar, L Peterson, V Wu, I Jenkins, M Muzi, J Specht, D Chen, J Link, ... Cancer Research 81 (4_Supplement), PD6-10-PD6-10, 2021 | | 2021 |
| Advances in positron emission tomographic imaging of lung cancer DL Chen, F Dehdashti Proceedings of the American Thoracic Society 2 (6), 541-544, 2005 | 36 | 2005 |
| Advancing Prostate Cancer Care: Treatment Approaches to Precision Medicine, Biomarker Innovations, and Equitable Access SE Fenton, DJ VanderWeeler, TR Rebbeck, DL Chen American Society of Clinical Oncology Educational Book 44 (3), e433138, 2024 | | 2024 |
| An obligatory role for club cells in preventing obliterative bronchiolitis in lung transplants Z Liu, F Liao, D Scozzi, Y Furuya, KN Pugh, R Hachem, DL Chen, M Cano, ... JCI insight 4 (9), 2019 | 28 | 2019 |
| Artificial intelligence in immunotherapy PET/SPECT imaging JP McGale, DL Chen, S Trebeschi, MD Farwell, AM Wu, CS Cutler, ... European Radiology, 1-13, 2024 | | 2024 |
| Association between PET-based TheraP eligibility and 177Lu-PSMA-617 (LuPSMA) outcomes in VISION-eligible patients with metastatic castration-resistant … RA Demirci, R Gulati, A Ghodsi, P Nelson, HH Cheng, JE Hawley, ... Journal of Clinical Oncology 42 (4_suppl), 41-41, 2024 | | 2024 |
| Association between SPECT/CT total tumor volume (TTV) and new lesions (NLs) in early cycles of 177Lu-PSMA-617 (LuPSMA) and progression-free and overall … RA Demirci, R Gulati, P Nelson, HH Cheng, JE Hawley, T Yezefski, ... Journal of Clinical Oncology 42 (4_suppl), 40-40, 2024 | | 2024 |
| Association of prior poly (ADP-ribose) polymerase (PARP) inhibitor therapy with response to 177Lu-PSMA-617 (LuPSMA) in men with DNA damage repair (DDR) mutations. R Raychaudhuri, G Mo, A Moradi Tuchayi, L Graham, R Gulati, ... Journal of Clinical Oncology 42 (4_suppl), 128-128, 2024 | | 2024 |
| Automated production of [18F] FluorThanatrace for clinical PET of poly (ADP-Ribose) polymerase activity in cancer D Zhou, C Bognar, G Gaehle, R Oyama, W Chu, D Chen Journal of Nuclear Medicine 58 (supplement 1), 871-871, 2017 | | 2017 |
| Automated production of a sphingosine-1 phosphate receptor 1 (S1P1) PET radiopharmaceutical [11C] CS1P1 for human use Z Luo, J Gu, RC Dennett, GG Gaehle, JS Perlmutter, DL Chen, ... Applied Radiation and Isotopes 152, 30-36, 2019 | 11 | 2019 |
| Baseline CD8 lymph node avidity with 89-Zr-crefmirlimab in patients with metastatic renal cell carcinoma and response to IO therapy. PD Zang, P Twardowski, DL Chen, ET Hall, D Hays, I Wilson, ... Journal of Clinical Oncology 42 (4_suppl), 375-375, 2024 | | 2024 |
| Best Practices for Limiting Treatment Cancellations of Lutetium-177 PSMA-617 M Erickson, Z Scherzer, L Toderas, E Yu, M Schweizer, A Iravani, D Chen, ... Journal of Nuclear Medicine 64 (supplement 1), P1590-P1590, 2023 | | 2023 |
